Filtros de búsqueda

Lista de obras de Dirk Schadendorf

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

90-year-old male with a hyperkeratotic lichenoid skin eruption

artículo científico publicado en 2005

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

article

A Dermatologist's Ammunition in the War Against Smoking: A Photoaging App.

artículo científico publicado en 2017

A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic

article

A Face-Aging App for Smoking Cessation in a Waiting Room Triggers Quitting: Pilot Study in an HIV Outpatient Clinic (Preprint)

article

A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Germany: Randomized Controlled Trial.

artículo científico publicado en 2017

A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study (Preprint)

article

A Skin Cancer Prevention Facial-Aging Mobile App for Secondary Schools in Brazil: Appearance-Focused Interventional Study.

artículo científico publicado en 2018

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task

artículo científico publicado en 2019

A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up

artículo científico publicado en 2011

A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition

artículo científico publicado en 2013

A landscape of driver mutations in melanoma

artículo científico publicado en 2012

A multimarker prognostic assay for primary cutaneous melanoma

artículo científico publicado en 2009

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

artículo científico publicado en 2008

A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope

artículo científico publicado en 2005

A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma

artículo científico publicado en 2017

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma.

artículo científico publicado en 2015

A rare primary sellar melanoma. Case report

artículo científico publicado en 2004

A skin cancer prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised controlled trial.

artículo científico publicado en 2018

A smoking prevention photoageing intervention for secondary schools in Brazil delivered by medical students: protocol for a randomised trial

artículo científico publicado en 2017

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms

artículo científico publicado en 2015

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

artículo científico publicado en 2017

Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors

artículo científico publicado en 2017

Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.

artículo científico publicado en 2016

Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma

artículo científico publicado en 2009

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

artículo científico publicado en 2017

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

artículo científico publicado en 2018

Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial

artículo científico publicado en 2020

Adjuvant melanoma therapy with new drugs: should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?

scientific article published on 01 December 2018

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2020

Adjuvant pegylated interferon α-2b therapy for melanoma

artículo científico publicado en 2010

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial ⬇️

artículo científico publicado en 2021

Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of C

artículo científico publicado en 2009

Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial

artículo científico publicado en 2020

Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group

artículo científico publicado en 2008

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

artículo científico publicado en 2018

Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG.

artículo científico publicado en 2018

Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers

artículo científico publicado en 2017

Adverse events 2.0-Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology

scientific article published on 21 March 2019

Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management

scientific article published on 19 August 2019

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.

artículo científico publicado en 2018

Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?

artículo científico publicado en 2004

An Animal Model of Cutaneous Cyst Development Enables the Identification of Three Quantitative Trait Loci, Including the Homologue of a Human Locus (TRICY1)

artículo científico publicado en 2019

An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma

artículo científico publicado en 2008

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study

artículo científico publicado en 2013

Analysis of SDHD promoter mutations in various types of melanoma

artículo científico publicado en 2015

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

artículo científico publicado en 2004

Analysis of dermatologic events in vemurafenib-treated patients with melanoma

artículo científico publicado en 2013

Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs

artículo científico publicado en 2006

Angioplasmacellular hyperplasia - a new histopathologic clue for anogenital herpes simplex recidivans in immunocompromised patients?

artículo científico publicado en 2014

Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.

artículo científico publicado en 2009

Antiretroviral therapy suppresses rectal HIV-RNA shedding despite inflammation in MSM with rectal C. trachomatis and N. gonorrhoeae infections-a cross-sectional, single-center study

artículo científico publicado en 2018

Antitumor activity of miR-1280 in melanoma by regulation of Src.

artículo científico publicado en 2014

Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma

scientific article published on 15 February 2019

Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression

scientific article published on 21 August 2020

Artificial Intelligence in Skin Cancer Diagnostics: The Patients' Perspective

artículo científico publicado en 2020

Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks

artículo científico publicado en 2015

Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in Melanoma

artículo científico publicado en 2019

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 02 January 2020

Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma

artículo científico publicado en 2012

Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors.

artículo científico publicado en 2010

Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition With Pembrolizumab Outcomes in Advanced Melanoma: Pooled Analysis of 3 Clinical Trials

artículo científico publicado en 2020

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.

artículo científico publicado en 2018

Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival

artículo científico publicado en 2011

Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles

artículo científico publicado en 2017

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition

artículo científico publicado en 2012

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

scientific article published on 19 June 2020

Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma

scientific article published on 01 April 2020

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

artículo científico publicado en 2007

B-type natriuretic peptides for the prediction of cardiovascular events and mortality in patients living with HIV: Results from the HIV-HEART study

scientific article published on 23 January 2019

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes

scientific article published on 04 December 2020

BRAF, MEK and KIT inhibitors for melanoma: adverse events and their management

artículo científico

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

artículo científico publicado en 2016

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

artículo científico publicado en 2016

Behavioural conditioning as the mediator of placebo responses in the immune system

artículo científico publicado en 2011

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.

artículo científico publicado en 2017

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced - or -mutated melanoma

Blood T-cell Vbeta transcriptome in melanoma patients

artículo científico publicado en 2004

Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

artículo científico publicado en 2011

CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival

artículo científico publicado en 2015

CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma

artículo científico publicado en 2015

COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients

scientific article published on 05 August 2020

Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

artículo científico publicado en 2018

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours

scientific article published on 12 March 2020

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

artículo científico publicado en 2018

Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy

artículo científico publicado en 2009

Candidate genes for cross-resistance against DNA-damaging drugs.

artículo científico publicado en 2002

Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: A meta-analysis of approximately 29,000 cancer patients

artículo científico publicado en 2018

Characterization of Gene Regulatory Elements for Selective Gene Expression in Human Melanoma Cells ⬇️

artículo científico publicado el 15 de agosto de 1995

Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient

artículo científico publicado en 2016

Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

artículo científico publicado en 2016

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

artículo científico publicado en 2017

Childhood psoriasis--an analysis of German health insurance data

artículo científico publicado en 2013

Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1

artículo científico publicado en 2020

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

artículo científico publicado en 2011

Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma

artículo científico publicado en 2014

Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma

scientific article published on 30 July 2018

Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity

artículo científico publicado en 2002

Clinical and genetic analysis of melanomas arising in acral sites

artículo científico publicado en 2019

Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine

article

Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma

artículo científico publicado en 2014

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.

artículo científico publicado en 2018

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

artículo científico publicado en 2016

Cognitive factors mediate placebo responses in patients with house dust mite allergy

artículo científico publicado en 2013

Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients

artículo científico publicado en 2002

Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology

artículo científico publicado en 2020

Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity.

artículo científico publicado en 2013

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

artículo científico publicado en 2014

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

artículo científico publicado en 2015

Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i

artículo científico publicado en 2020

Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells

artículo científico publicado en 2006

Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study

artículo científico publicado en 2008

Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma.

artículo científico publicado en 2015

Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.

artículo científico publicado en 2002

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark

article

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o

article

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

artículo científico publicado en 2003

Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun's Nuclear Translocation and Activity

scientific article published on 17 November 2019

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas

artículo científico publicado en 2013

Conjunctival melanomas harbor BRAF and NRAS mutations--response

artículo científico publicado en 2013

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

artículo científico publicado en 2019

Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials.

artículo científico publicado en 2015

Corrigendum to 'Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data' [Eur J Cancer, 119 (September 2019) Pages 30-34]

scientific article published on 07 November 2019

Corrigendum to “Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*” [Eur J Cancer 91 (2018) 116–124]

artículo científico publicado en 2018

Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.

artículo científico publicado en 2016

Corticosteroids augment BRAF inhibitor vemurafenib induced lymphopenia and risk of infection

artículo científico publicado en 2015

Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma

artículo científico publicado en 2014

Current advances and perspectives in the treatment of advanced melanoma

artículo científico publicado en 2012

Cutaneous melanoma: a model to study cancer metastasis

scientific article published on May 2011

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

artículo científico publicado en 2016

Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma

artículo científico publicado en 2012

Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis

artículo científico publicado en 2017

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

artículo científico publicado en 2015

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

artículo científico publicado en 2012

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

artículo científico publicado en 2005

Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications

artículo científico publicado en 2020

Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images

artículo científico publicado en 2019

Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task

scientific article published on 10 April 2019

Deep neural networks are superior to dermatologists in melanoma image classification

scientific article published on 08 August 2019

Detection of abacavir hypersensitivity by ELISpot method

artículo científico publicado en 2012

Detection of spontaneous CD4+ T-cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic mice

artículo científico publicado en 2005

Detergent fractionation with subsequent subtractive suppression hybridization as a tool for identifying genes coding for plasma membrane proteins

artículo científico publicado en 2009

Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature

artículo científico publicado en 2016

Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach

article

Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.

artículo científico publicado en 2006

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

artículo científico publicado en 2009

Disease kinetics for decision-making in advanced melanoma: a call for scenario-driven strategy trials

artículo científico

Disseminated cutaneous Kaposi sarcoma and progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia

scientific article published on 01 May 2007

Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells

artículo científico publicado en 2009

Dose Seeking Evaluation of a Novel Heterologous Primeboost Immunotherapy in Stage III and IV Metastatic Melanoma Patients

Dose-dependent toxicity of ipilimumab in metastatic melanoma

scientific article published on 21 February 2018

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

artículo científico publicado en 2004

Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency

artículo científico publicado en 2002

Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis

scientific article published on 02 April 2020

Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case Report

scientific article published on 11 November 2020

ECG Changes in Melanoma Patients Undergoing Cancer Therapy-Data From the ECoR Registry

artículo científico publicado en 2020

EORTC Melanoma Group achievements

artículo científico publicado en 2012

ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope

scientific article published on 27 November 2019

ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma

Effect of a Face-Aging Mobile App-Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil: A Cluster-Randomized Clinical Trial

scientific article published on 06 May 2020

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

artículo científico publicado en 2005

Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides.

artículo científico publicado en 2003

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

artículo científico

Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control

article

Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

scientific article published on 15 June 2019

Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial

artículo científico publicado en 2010

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III.

artículo científico publicado en 2017

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.

artículo científico publicado en 2018

Endogenous μ-opioid peptides modulate immune response towards malignant melanoma

artículo científico publicado en 2010

Endoprotease profiling with double-tagged peptide substrates: a new diagnostic approach in oncology

artículo científico publicado en 2010

Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells

artículo científico publicado en 2008

Enhanced P-Selectin Expression in Chronic and Dermographic Urticaria ⬇️

artículo científico publicado el 1 de septiembre de 1997

Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma

artículo científico publicado en 2011

Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey

artículo científico publicado en 2010

Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients

artículo científico publicado en 2008

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

artículo científico publicado en 2019

Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-(99m)Tc-nanocolloid hybrid tracer versus (99m)Tc-nanocolloid.

artículo científico publicado en 2015

Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma

artículo científico publicado en 2003

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

artículo científico publicado en 2017

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma

artículo científico publicado en 2007

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

artículo científico publicado en 2008

Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.

artículo científico publicado en 2008

Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment

scientific article published on 18 April 2018

Expanded access programmes: patient interests versus clinical trial integrity

artículo científico publicado en 2014

Expectation-induced placebo responses fail to accelerate wound healing in healthy volunteers: results from a prospective controlled experimental trial

artículo científico publicado en 2013

Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS)

artículo científico publicado en 2016

Expression of GAGE family proteins in malignant melanoma

artículo científico publicado en 2006

Expression of stress ligands of the immunoreceptor NKG2D in melanoma: regulation and clinical significance

artículo científico publicado en 2014

Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.

artículo científico publicado en 2002

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).

artículo científico publicado en 2011

Facial-Aging App Availability in Waiting Rooms as a Potential Opportunity for Skin Cancer Prevention

artículo científico publicado en 2018

Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials

artículo científico publicado en 2016

Fatal swelling of the groin - Clear cell sarcoma: a rare but important differential diagnosis to malignant melanoma

artículo científico publicado en 2020

Fear of cancer progression in patients with stage IA malignant melanoma

artículo científico publicado en 2018

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.

artículo científico publicado en 2017

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

scientific article published on 26 February 2019

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

scientific article published on 02 September 2020

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

artículo científico publicado en 2020

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

artículo científico publicado en 2019

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

artículo científico publicado en 2019

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K-mutant advanced or metastatic melanoma.

artículo científico publicado en 2019

Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma

scientific article published on 01 March 2011

Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma

artículo científico publicado en 2017

Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi.

artículo científico publicado en 2019

Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia.

artículo científico publicado en 2015

Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.

artículo científico publicado en 2010

Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

Functional CCR9 expression is associated with small intestinal metastasis

artículo científico publicado en 2004

Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis

artículo científico publicado en 2012

GBP-5 splicing variants: New guanylate-binding proteins with tumor-associated expression and antigenicity

artículo científico publicado en 2004

Gene-based immunotherapy of skin cancers.

artículo científico publicado en 2002

Gene-based therapy of malignant melanoma

artículo científico publicado en 2002

Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition

artículo científico publicado en 2014

Genetic alterations and personalized medicine in melanoma: progress and future prospects

artículo científico

Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival

artículo científico publicado en 2022

Genetic and clinico-pathologic analysis of metastatic uveal melanoma

artículo científico publicado en 2013

Genetic and morphologic features for melanoma classification

artículo científico publicado en 2010

Genetic evolution of T-cell resistance in the course of melanoma progression

artículo científico publicado en 2014

Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility

artículo científico publicado en 2020

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma ⬇️

artículo científico publicado en 2015

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

artículo científico publicado en 2015

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

artículo científico publicado en 2018

Giant pilomatricoma: a benign tumor in an uncommon presentation

artículo científico publicado en 2009

Good shedder or bad shedder--the influence of skin diseases on forensic DNA analysis from epithelial abrasions.

artículo científico publicado en 2011

HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy

artículo científico publicado en 2019

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model

artículo científico publicado en 2017

Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma

artículo científico publicado en 2015

Health-related quality of life in patients with fully resected BRAFV600 mutation-positive melanoma receiving adjuvant vemurafenib.

artículo científico publicado en 2019

Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma

artículo científico publicado en 2016

Health-related quality of life results from the phase III CheckMate 067 study.

artículo científico publicado en 2017

High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma

artículo científico publicado en 2016

Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth

artículo científico publicado en 2009

How melanoma is treated in real life

artículo científico publicado en 2008

Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.

artículo científico publicado en 2008

Human melanoma: drug resistance

artículo científico publicado en 2003

Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells

artículo científico publicado en 2004

IL-12 production by human monocyte-derived dendritic cells: looking at the single cell

artículo científico publicado en 2005

IRF4 rs12203592 functional variant and melanoma survival.

artículo científico publicado en 2017

Identification of a cross-reactive HLA-DRB1*0301-restricted CD4 T cell response directed against cholesterol-binding cytolysins from two different pathogens

artículo científico publicado en 2006

Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy

artículo científico publicado en 2006

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.

artículo científico publicado en 2002

Identification of selectively expressed genes and antigens in CTCL.

artículo científico publicado en 2007

Identification of tumor antigens and T-cell epitopes, and its clinical application

artículo científico publicado en 2003

Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

artículo científico publicado en 2007

Imatinib in melanoma: a selective treatment option based on KIT mutation status?

scientific article published on 01 March 2007

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients

artículo científico publicado en 2020

Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma

artículo científico publicado en 2017

Immunogenicity of constitutively active V599EBRaf

artículo científico publicado en 2004

Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins

artículo científico publicado en 2006

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

artículo científico publicado en 2018

Immunotherapy in non-melanoma skin cancer: updates and new perspectives

Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma

scientific article published on 08 August 2019

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG

scientific article published on 01 May 2020

Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy

artículo científico publicado en 2007

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

artículo científico publicado en 2010

Improved overall survival in melanoma with combined dabrafenib and trametinib

artículo científico publicado en 2015

Improved survival with MEK inhibition in BRAF-mutated melanoma

artículo científico publicado en 2012

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

artículo científico publicado en 2011

In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.

artículo científico publicado en 2006

In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons ⬇️

artículo científico publicado el 1 de agosto de 1994

Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.

artículo científico publicado en 2013

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

artículo científico publicado en 2016

Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort ⬇️

artículo científico publicado en 2015

Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma

scientific article published on 04 May 2020

Indocyanine green fluorescence-guided sentinel lymph node biopsy in dermato-oncology

artículo científico publicado en 2011

Influence of genetic variants in type I interferon genes on melanoma survival and therapy

artículo científico publicado en 2012

Information-seeking and use of information resources among melanoma patients of German skin cancer centers

artículo científico publicado en 2018

Informations- und Hilfsangebote für Melanompatienten: Präferenzielle Unterschiede zwischen Patienten und Ärzten

scientific article published on 01 June 2019

Informationssuche und Nutzung von Informationsquellen durch Melanompatienten deutscher Hautkrebszentren

artículo científico publicado en 2018

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival

artículo científico publicado en 2016

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study

artículo científico publicado en 2012

Inherited variation in the PARP1 gene and survival from melanoma

artículo científico publicado en 2014

Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity

artículo científico publicado en 2019

Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis

scientific article published on July 2016

Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling

artículo científico publicado en 2018

Integrated molecular drivers coordinate biological and clinical states in melanoma

artículo científico publicado en 2020

Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

publication published on 02 July 2021

Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?

artículo científico

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

scientific article published on 02 December 2019

Integrin genes and susceptibility to human melanoma.

artículo científico publicado en 2011

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group ⬇️

artículo científico publicado el 1 de julio de 1997

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

artículo científico publicado en 2009

Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.

artículo científico publicado en 2012

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial

artículo científico publicado en 2015

Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis

scientific article published on 01 May 2013

Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen

artículo científico publicado en 2003

Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes

artículo científico

Intraoperative use of LIGHTVISION: a novel fluorescence navigation system using indocyanine green for sentinel lymph node biopsy in skin cancer patients

artículo científico publicado en 2018

Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma

artículo científico publicado en 2003

Intraventricular melanocytoma diagnosis confirmed by gene mutation profile

artículo científico publicado en 2017

Investigation of adhesion of modern wound dressings: a comparative analysis of 56 different wound dressings ⬇️

artículo científico publicado el 10 de noviembre de 2010

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

artículo científico publicado en 2017

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

artículo científico publicado en 2017

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials

artículo científico publicado en 2010

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

artículo científico publicado en 2009

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?

artículo científico publicado en 2013

Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma.

artículo científico publicado en 2006

Lack of SF3B1 R625 mutations in cutaneous melanoma

artículo científico publicado en 2013

Laudatio anlässlich der Emeritierung von Prof. Dr. Claus Garbe (Tübingen)

scientific article published on 01 November 2019

Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanoma.

artículo científico publicado en 2013

Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients

artículo científico publicado en 2003

Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients

artículo científico publicado en 2003

Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy.

artículo científico publicado en 2018

Local cutaneous argyria mimicking melanoma metastases in a patient with disseminated melanoma

artículo científico publicado en 2006

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials

scientific article published on 01 January 2020

Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma

artículo científico publicado en 2012

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

artículo científico publicado en 2017

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

scientific article published on 18 September 2020

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma

article

MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy

artículo científico publicado en 2017

MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients

artículo científico publicado en 2018

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

artículo científico publicado en 2013

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome ⬇️

artículo científico publicado el 24 de agosto de 2010

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series

scientific article published on 16 April 2019

MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma

artículo científico publicado en 2004

MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma

artículo científico publicado en 2015

Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain

scientific article published on 05 February 2020

Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

artículo científico publicado en 2013

Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents

artículo científico publicado en 2016

Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq

artículo científico publicado en 2016

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts

artículo científico publicado en 2016

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations

artículo científico publicado en 2009

Melanoma

2015 article in Nature Reviews Disease Primers

Melanoma

artículo científico publicado en 2018

Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency

artículo científico publicado en 2016

Melanoma and immunotherapy

artículo científico publicado en 2009

Melanoma brain metastases - Interdisciplinary management recommendations 2020

artículo científico publicado en 2020

Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells

artículo científico publicado en 2005

Melanoma diagnosed in lesions previously treated by laser therapy

artículo científico publicado en 2016

Melanoma genome sequencing reveals frequent PREX2 mutations

artículo científico publicado en 2012

Melanoma in 2013: Melanoma--the run of success continues

artículo científico

Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.

artículo científico publicado en 2005

Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis

artículo científico publicado en 2020

Melanoma risk factors, perceived threat and intentional tanning: an international online survey

artículo científico publicado en 2010

Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.

artículo científico publicado en 2006

Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors

artículo científico publicado en 2008

Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs

artículo científico publicado en 2016

Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?

artículo científico publicado en 2019

Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease

artículo científico publicado en 2014

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

artículo científico publicado en 2006

Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging.

artículo científico publicado en 2015

MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.

artículo científico publicado en 2013

Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response

artículo científico publicado en 2007

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations

artículo científico publicado en 2015

Mixed effect modelling of proteomic mass spectrometry data by using Gaussian mixtures

article

Molecular features of response to anti-PD-1 therapy

artículo científico publicado en 2016

Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors

artículo científico

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

artículo científico publicado en 2008

Multiple Melanomas After Treatment for Hodgkin Lymphoma in a Non-Dutch p16-Leiden Mutation Carrier With 2 MC1R High-Risk Variants

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

artículo científico publicado en 2015

Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells

artículo científico publicado en 2013

NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils

scientific article published on 30 October 2018

Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up

artículo científico publicado en 2013

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

artículo científico publicado en 2016

Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth

artículo científico publicado en 2012

New developments in biomarkers for melanoma

artículo científico

New promises in the adjuvant, and palliative treatment of melanoma.

artículo científico publicado en 2007

Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials

artículo científico publicado en 2017

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

article

Nivolumab in previously untreated melanoma without BRAF mutation

artículo científico publicado en 2015

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Nodular scabies: hypersensitivity reaction or infection?

artículo científico publicado en 2011

Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma

artículo científico publicado en 2010

Obituary for Prof. Dr. med. Christiane Voit (Berlin)

artículo científico publicado en 2015

Oncogene Status of an Interdigitating Dendritic Cell Sarcoma: Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma

artículo científico publicado en 2016

Oncogene status as a diagnostic tool in ocular and cutaneous melanoma

artículo científico publicado en 2016

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma.

artículo científico publicado en 2015

Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial

artículo científico publicado en 2018

Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.

artículo científico publicado en 2017

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

artículo científico publicado en 2017

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

scientific article published on 01 June 2020

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2018

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials.

artículo científico publicado en 2014

Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

artículo científico publicado en 2003

Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term Therapy

artículo científico publicado en 2017

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma

artículo científico publicado en 2017

PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells

artículo científico publicado en 2010

PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer

artículo científico publicado en 2018

PLX4032: does it keep its promise for metastatic melanoma treatment?

artículo científico publicado en 2010

Panel sequencing melanomas

artículo científico publicado en 2015

Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management

artículo científico publicado en 2012

Pathologist-level classification of histopathological melanoma images with deep neural networks

scientific article published on 23 May 2019

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

scientific article published on 27 March 2019

Patient-reported outcomes with nivolumab in advanced solid cancers

artículo científico publicado en 2018

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

scientific article published on 21 November 2020

Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade

artículo científico publicado en 2018

Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanoma

artículo científico publicado en 2010

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

artículo científico publicado en 2015

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

artículo científico publicado en 2017

Peroxisome proliferator-activating receptors: a new way to treat melanoma?

artículo científico publicado en 2009

Persister state-directed transitioning and vulnerability in melanoma

artículo científico publicado en 2022

Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma

scientific article published on 23 July 2018

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

artículo científico publicado en 2015

Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma

artículo científico publicado en 2013

Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma

artículo científico publicado en 2015

Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma

artículo científico publicado en 2016

Photoaging Mobile Apps as a Novel Opportunity for Melanoma Prevention: Pilot Study.

artículo científico publicado en 2017

Photoaging Mobile Apps in School-Based Melanoma Prevention: Pilot Study.

artículo científico publicado en 2017

Photopheresis in pediatric patients with low-body weight using the UVAR XTS system

artículo científico publicado en 2009

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?

artículo científico publicado en 2010

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

artículo científico publicado en 2015

Postsurgical Treatment of Split Skin Graft Donor Sites in Dermatological Departments

artículo científico publicado en 2018

Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data

scientific article published on 08 August 2019

Predictors of sun protection behaviors and severe sunburn in an international online study

artículo científico publicado en 2010

Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma

scientific article published on 13 January 2020

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

artículo científico publicado en 2016

Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study

artículo científico publicado en 2012

Primary tumor versus metastasis: new experimental models for studies on cancer cell homing and metastasis in melanoma

artículo científico publicado en 2014

Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

artículo científico publicado en 2020

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

scientific article published on 11 June 2019

Prognostic factors for pulmonary metastasectomy in malignant melanoma: size matters

artículo científico publicado en 2019

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients

article

Prognostische Genexpressionstests beim Melanom auf dem Weg in die Routine

artículo científico publicado en 2020

Prolongation of the QTc interval in HIV-infected individuals compared to the general population

artículo científico publicado en 2017

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab ⬇️

artículo científico publicado en 2016

Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial

artículo científico publicado en 2011

Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.

artículo científico publicado en 2009

Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis

scientific article published on 01 August 2003

Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification

artículo científico publicado en 2013

Quality, Readability, and Understandability of German Booklets Addressing Melanoma Patients

artículo científico publicado en 2019

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors

artículo científico publicado en 2011

Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG)

artículo científico publicado en 2003

Rapid progression of a splenic aneurysm due to segmental arterial mediolysis: A rare cause of acute pancreatitis

artículo científico publicado en 2013

Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review

artículo científico publicado en 2020

Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk

article published in 2006

Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912)

artículo científico publicado en 2018

Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study

artículo científico publicado en 2018

Recoverin as a cancer-retina antigen

artículo científico publicado en 2007

Reply to E. Hindié and K.R. Hess

artículo científico publicado en 2019

Reply to M. Horiguchi et al.

artículo científico publicado en 2018

Reply to M. Perier-Muzet et al

scientific article published on 02 September 2014

Reply to the letter to the editor: 'Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images'

artículo científico publicado en 2020

Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma

artículo científico publicado en 2010

Response

artículo científico publicado en 2015

Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype ⬇️

artículo científico publicado el 1 de febrero de 1993

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

artículo científico publicado en 2009

Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study

artículo científico publicado en 2013

Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma

artículo científico publicado en 2018

Role of apaf-1 in melanoma drug resistance and apoptosis.

artículo científico publicado en 2005

S3-Leitlinie Diagnostik, Therapie und Nachsorge des Melanoms - Update 2015/2016, Kurzversion 2.0.

artículo científico publicado en 2017

S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version

artículo científico publicado en 2013

SEREX identification of new tumor antigens linked to melanoma-associated retinopathy

artículo científico publicado en 2005

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma

artículo científico publicado en 2016

SF3B1 and BAP1 mutations in blue nevus-like melanoma

artículo científico publicado en 2017

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients

artículo científico publicado en 2014

STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.

artículo científico publicado en 2018

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma

artículo científico publicado en 2016

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 30 September 2019

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 21 August 2019

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

artículo científico publicado en 2014

Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia: a prospective study

artículo científico publicado en 2020

Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries

artículo científico publicado en 2010

Sebaceous tumours: more than skin deep

artículo científico publicado en 2017

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study

artículo científico publicado en 2013

Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial

artículo científico publicado en 2019

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies

artículo científico publicado en 2007

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

scientific article published on 01 December 2020

Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling

artículo científico publicado en 2009

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients

artículo científico publicado en 2005

Sexual risk behavior, sexually transmitted infections, and HIV transmission risks in HIV-positive men who have sex with men (MSM) - approaches for medical prevention

artículo científico publicado en 2017

Sexualverhalten, STIs und HIV-Übertragungsrisiken bei HIV-positiven MSM - Ansätze für die ärztliche Präventionsarbeit

artículo científico publicado en 2017

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation

artículo científico publicado en 2014

Short German guidelines: malignant melanoma

artículo científico publicado en 2008

Side effects of systemic oncological therapies in dermatology

artículo científico

Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients

artículo científico publicado en 2008

Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma

article

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA

artículo científico publicado en 2016

Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

scholarly article by Titus Josef Brinker et al published 17 October 2018 in Journal of Medical Internet Research

Skin Cancer Classification using Convolutional Neural Networks: Systematic Review (Preprint)

scholarly article published 14 August 2018

Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination

artículo científico publicado en 2012

Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs

scientific article published on 19 October 2009

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study

artículo científico publicado en 2010

Sources of information and support for melanoma patients: differences between patients' and clinicians' preferences

artículo científico publicado en 2019

Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression

artículo científico publicado en 2017

Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study

artículo científico publicado en 2014

Steroid-induced periorificial dermatitis in children--clinical features and response to azelaic acid

artículo científico publicado en 2009

Study of the development of chemoresistance in melanoma cell lines using proteome analysis

artículo científico publicado en 2003

Study of therapy resistance in cancer cells with functional proteome analysis

artículo científico publicado en 2002

Subacute cutaneous lupus erythematosus on the lines of Blaschko.

artículo científico publicado en 2006

Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

artículo científico publicado en 2014

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

scientific article published on 01 February 2019

Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019

scientific article published on 13 March 2020

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

artículo científico

Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.

artículo científico publicado en 2017

Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

scientific article published on 03 September 2019

Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks

artículo científico publicado en 2019

Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma

artículo científico publicado en 2017

Systemic therapies for melanoma brain metastases: which drug for whom and when?

artículo científico

T CELL REPERTOIRE IN COMBINATION WITH T CELL DENSITY PREDICTS CLINICAL OUTCOMES IN PATIENTS WITH MERKEL CELL CARCINOMA

artículo científico publicado en 2020

T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma

artículo científico publicado en 2012

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

artículo científico publicado en 2014

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

artículo científico publicado en 2013

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

artículo científico publicado en 2013

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

artículo científico publicado en 2013

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway

artículo científico publicado en 2015

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations

artículo científico publicado en 2017

Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system

artículo científico publicado en 2016

Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.

artículo científico publicado en 2017

Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination

artículo científico publicado en 2012

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

scientific article published on 03 February 2013

Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells

scientific article published on 21 June 2019

Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy

scientific article published on 19 May 2020

Teledermatology: Comparison of Store-and-Forward Versus Live Interactive Video Conferencing

article by Titus Josef Brinker et al published 24 October 2018 in Journal of Medical Internet Research

Teledermatology: Comparison of Store-and-Forward Versus Live Interactive Video Conferencing (Preprint)

article

Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk

scientific article published on 11 September 2018

Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group

artículo científico publicado en 2005

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

artículo científico publicado en 2020

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Era of Checkpoint Inhibition: Lessons Learned from Melanoma

scientific article published on 01 January 2020

The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression

artículo científico publicado en 2017

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

artículo científico publicado en 2019

The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific

artículo científico publicado en 2006

The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma

artículo científico publicado en 2006

The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions

scientific article published on 26 August 2020

The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases

artículo científico publicado en 2012

The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells

artículo científico publicado en 2010

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

artículo científico publicado en 2013

The impact of the immune system on tumor: angiogenesis and vascular remodeling

scientific article published on 08 April 2014

The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes.

artículo científico publicado en 2005

The new face of nucleolin in human melanoma

artículo científico publicado en 2009

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians.

artículo científico publicado en 2018

The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma

artículo científico publicado en 2011

The predictive and prognostic significance of cell-free DNA concentration in melanoma

scientific article published on 22 June 2020

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

artículo científico publicado en 2013

The prognostic value of sentinel lymph nodes on distant metastasis-free survival in patients with high-risk squamous cell carcinoma

artículo científico publicado en 2019

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

artículo científico publicado en 2016

The role of the proteasome activator PA28 in MHC class I antigen processing

artículo científico publicado en 2002

The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma

artículo científico publicado en 2017

The use of histamine in cancer immunotherapy

artículo científico publicado en 2002

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials

artículo científico publicado en 2017

Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer

artículo científico publicado en 2004

Treatment algorithms in stage IV melanoma

artículo científico

Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe

artículo científico publicado en 2016

Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.

artículo científico publicado en 2012

Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance

artículo científico publicado en 2018

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

artículo científico publicado en 2019

Tumor regression and sirolimus-based therapy in lung transplantation

artículo científico publicado en 2013

Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.

artículo científico publicado en 2011

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

artículo científico publicado en 2005

Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genes

artículo científico publicado en 2002

Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity

artículo científico publicado en 2003

Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

artículo científico publicado en 2017

Tödliche Schwellung der Leiste - Klarzellsarkom: eine seltene, aber wichtige Differenzialdiagnose zum malignen Melanom

artículo científico publicado en 2020

Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.

artículo científico publicado en 2011

Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma

artículo científico publicado en 2014

Unmet information needs of patients with melanoma in Germany

artículo científico publicado en 2019

Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management

artículo científico publicado en 2010

Update on the clinical use of kinase inhibitors in melanoma

artículo científico publicado en 2017

Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma

scientific article published on 02 January 2020

Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim Melanom

artículo científico publicado en 2017

Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients

artículo científico publicado en 2013

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

scientific article published on 01 March 1998

Valvular manifestations of human immunodeficiency virus infection--results from the prospective, multicenter HIV-HEART study

artículo científico publicado en 2013

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells

artículo científico publicado en 2013

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

artículo científico publicado en 2013

Visible light modulates the expression of cancer-retina antigens

artículo científico publicado en 2008

Vitamin A metabolism in benign and malignant melanocytic skin cells: importance of lecithin/retinol acyltransferase and RPE65.

artículo científico publicado en 2012

Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective study

scientific article published on 10 April 2020

Willingness to pay for a cure of low-risk melanoma patients in Germany.

artículo científico publicado en 2018

[Acute juvenile pityriasis rubra pilaris in a 2-year-old child]

artículo científico publicado en 2004

[Brief guidelines: malignant melanoma of the skin]

artículo científico publicado en 2006

[Editorial]

artículo científico publicado en 2016

[Entscheidungsfindung für die klinische Praxis: Aktuelle Konzepte und Behandlungsalgorithmen mit Immun-Checkpoint-Inhibitoren beim Melanom].

artículo científico publicado en 2016

[External scientific evaluation of the first teledermatology app without direct patient contact in Germany (Online Dermatologist-AppDoc)]

artículo científico publicado en 2020

[Foreword]

artículo científico publicado en 2012

[Foreword].

artículo científico publicado en 2013

[Forward: anti-tumor immunity and tumor immunology]

artículo científico publicado en 2014

[Forward]

artículo científico publicado en 2011

[Immuno-Oncology "Coming of Age" - the next generation of immune checkpoint inhibitors ]

artículo científico publicado en 2014

[Klippel-trénaunay syndrome - a rare cause of a chronic leg ulcer]

scientific article published on 01 November 2010

[Malignant melanoma]

scientific article published on 23 March 2020

[Malignant melanoma]

artículo científico publicado en 2020

[Merkel cell carcinoma]

scientific article published on 01 March 2019

[Preface]

artículo científico publicado en 2015

[Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma].

artículo científico publicado en 2011

[Vorwort]

artículo científico publicado en 2016

[Working group of the Dermatologic Oncology]

artículo científico publicado en 2009

cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca(2+) homeostasis in melanoma cells

artículo científico publicado en 2010

cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing

artículo científico publicado en 2003

mRNA expression of tumor-associated antigens in melanoma tissues and cell lines

artículo científico publicado en 2002

miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes

artículo científico publicado en 2012

miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.

artículo científico publicado en 2015

pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.

artículo científico publicado en 2012

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda